Filetype
Aurelija LukosevicieneAuthors and Creative UsersAddressing the Conceptual Challenges of Digital Creativity to EU Copyright Law from the Perspective of the AuthorDatum för disputation: fredagen den 1 oktober 2021Fakultetsopponent: Professor Ole Andreas Rognstad, Oslo universitetÄmne: civilrättAbstractTo be an “author” might mean many different things, depending on the context in which the word is u
https://www.jur.lu.se/forskning/disputationer/disputationer-2021 - 2026-05-03
My bachelor’s degree is in: Biochemistry My bachelor’s degree is from: University of Geneva I graduated year: 2017 My master’s degree is in: Organic Chemistry My master’s degree is from: Lund University I graduated year: 2019 I am now a PhD candidate in Organic Chemistry at UiT The Arctic University of Norway, where I work with photoredox catalysis (generation of radicals by irradiation with visib
https://www.kemi.lu.se/floriane-baussiere-phd-candidate - 2026-05-03
‘Killer acquisitions’ are fairly a new phenomenon which stems from a researcher’s study related to concerns from a series of mergers in the pharmaceutical industry (Big Pharma) around 2018. Killer acquisitions occur in the pharmaceutical sector and also in large digital and technological markets occupied by large companies (Big Tech). They are putting themselves into a position of overwhelming mar
The purpose of this thesis is to discuss and analyze how constructions of masculinity and femininity are intertwined with land-related corruption in Vietnam. Drawing on masculinity theory and Nancy Fraser’s conceptualization of institutionalized injustice and participatory parity the thesis examines the relation between kinship systems and corruption and whether corruption leads to increased use o
In Sweden 4200 patients are diagnosed with lung cancer and 6500 patients with colorectal cancer (CRC) annually. The lungs are a common site for metastases. Immunohistochemistry (IHC) is a helpful aid in diagnostics of a pulmonary tumour. Selected patients with metastatic CRC undergo pulmonary metastasectomy and knowledge about which patients benefit from it is important. In this thesis IHC markers
PowerPoint Presentation Heat in Cities: Spatial and Social Dimensions David M. Hondula, PhD Assistant Research Professor Center for Policy Informatics & School of Geographical Sci. and Urban Planning Arizona State University Jennifer Vanos, PhD Assistant Professor of Atmospheric Sciences Department of Geosciences Climate Science Center Faculty Associate Texas Tech University Average Monthly High T
https://www.pi.lu.se/sites/pi.lu.se/files/heat-conference_2.pptx - 2026-05-05
NYTT FRÅN LUNDS UNIVERSITET Mejlutskick på svenska och engelska som vänder sig till fakultetskommunikatörer vid Lunds universitet för vidarespridning i fakultets- och institutionskanaler – Nr 31 v 40 - 2020. UNIVERSITETSGEMENSAMT Universitetet satsar på specialteam för att förebygga sexuella trakasserier efter Tellus-rapport* Vid ett webbinarium den 28 september presenterades resultaten från under
https://www.cec.lu.se/sites/cec.lu.se/files/2020-10/LU-gemensamt%20Mejlutskick%20Nr%2031-2020-v40.pdf - 2026-05-04
Call for papers: World Human Rights Cities Forum - The Raoul Wallenberg Institute of Human Rights and Humanitarian Law Skip to content Search for: Search Button Home About Us Who We Are Our History About Raoul Wallenberg Our Theory of Change Staff Opportunities Annual Reports Whistleblower Our work What we do Multi-Disciplinary Research Higher Education Strategic Advice and Analysis Outreach Evalu
https://rwi.lu.se/news/call-for-papers-world-human-rights-cities-forum-2/ - 2026-05-05
Adjungerad universitetslektor Kontaktinformation E-post: matthew [dot] scott [at] rwi [dot] lu [dot] seOrganisation Juridiska institutionen Rumsnummer: 435 Hämtställe: 56 WebbplatsMatthew Scotts profil i Lunds universitets forskningsportalAndra roller Docent Juridiska institutionen Profilområdesmedlem LU profilområde: Mänskliga rättigheter Forskare Raoul Wallenberg institutet för mänskliga rättigh
https://www.jur.lu.se/matthew-scott - 2026-05-04
Checklista för uppdragsavtal Forskningsservice Sophie Hydén Picasso Finansieringsmetoder för excellens PLANERA EN AKADEMISK KARRIÄR En akademisk karriär är ofta mångfacetterad, och dess olika delar ställer krav på olika typer av egenskaper och färdigheter. Olika karriärprofiler och vägar framåt kan överlappa och kombineras, alternativt så rör man sig mer etappvis längst karriärvägen. Forskning, un
https://www.medarbetarwebben.lu.se/sites/medarbetarwebben.lu.se/files/finansieringsmetoder-for-excellens.pdf - 2026-05-05
Innovation highlights at Lund University 2025–2026 Innovation highlights at Lund University 2025–2026 ► The numbers tell the story: strong year for new ideas ► Innovation supports research goals ► Funding opportunities 2026 + Supplement – Dive into news from research spin-outs ” Innovation: Integral to a globally ambitious leading university Ph o to : K en n et R o u n a At Lund University, impact
https://www.innovation.lu.se/sites/innovation.lu.se/files/2026-03/401281-Magasin-FINAL-lowres_0.pdf - 2026-05-04
Professor (tjänstledig) Kontaktinformation E-post: ulf [dot] linderfalk [at] jur [dot] lu [dot] seOrganisation Juridiska institutionen Hämtställe: 56 WebbplatsUlf Linderfalks profil i Lunds universitets forskningsportalAndra roller Forskare (tjänstledig) Folkrätt Forskningskoordinator (tjänstledig) Folkrätt Publikationer Visar av publikationer. Sorterade efter år och sen titel. Filtrera efter typ
https://www.jur.lu.se/ulf-linderfalk - 2026-05-04
Background: A unique feature of alveolar mast cells is their low high-affinity IgE receptor (FcεRI) expression. Recent discoveries in uncontrolled asthma suggest that the appearance of FcεRI-expressing alveolar mast cells may be a novel disease-specific feature of allergic asthma. This study investigates whether increased FcεRI-expressing alveolar mast cells are present in patients with mild aller
This review compares the methodology of published clinical studies investigating the extended-half-life (EHL) factor VIII (FVIII) products, rFVIIIFc (efmoroctocog alfa, Elocta®/Eloctate®), BAY 94-9027 (damoctocog alfa pegol, Jivi®), BAX 855 (rurioctocog alfa pegol, Adynovate®) and N8-GP (turoctocog alfa pegol, Esperoct®) including the phase 2/3 studies, A-LONG (NCT01181128), PROTECT VIII (NCT01580
